https://www.adnkronos.com/salute/mielofibrosi-ematologo-passamonti-momelotinib-migliora-livelli-emoglobina_5OdsUl1rHSg0xGBX5e1ylQ
'Effetto unico rispetto agli altri Jak inibitori disponibili in Italia'
momelotinib
https://www.businesswire.com/news/home/20220526005724/en/Momelotinib-Pivotal-Phase-3-Data-Receives-Oral-Presentation-at-American-Society-of-Clinical-Oncology-Annual-Meeting
Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announc...
oral presentationmomelotinibpivotalphasedata